Related Experiment Video
Updated: Dec 21, 2025
06:55
Assessment of Maternal Vascular Remodeling During Pregnancy in the Mouse Uterus
Published on: December 5, 2015
13.9K
Summary
Thrombotic microangiopathy (TMA) is a critical condition involving anemia, low platelets, and organ damage. Persistent symptoms post-delivery warrant considering TMAs beyond HELLP syndrome.
Area of Science:
- Nephrology
- Hematology
- Obstetrics
Background:
- Thrombotic microangiopathy (TMA) is a severe condition.
- Characterized by microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and organ dysfunction.
- Often presents as HELLP syndrome in pregnant patients.
Observation:
- Persistent HELLP syndrome symptoms beyond 48-72 hours postpartum necessitate considering other TMAs.
- Two case reports of TMA are presented.
- Literature review highlights the complexities of TMA.
Findings:
- TMA requires a multidisciplinary approach involving obstetricians, anesthesiologists, nephrologists, and hematologists.
- Differential diagnostic and therapeutic schemes are crucial for effective management.
- Early recognition and intervention are key.
Implications:
- Highlights the importance of recognizing TMA beyond typical presentations.
- Emphasizes the need for collaborative care in managing complex TMA cases.
- Provides a framework for differential diagnosis and treatment strategies.
Keywords:
HELLP syndromeacute fatty liver of pregnancyatypical hemolytic uremic syndromeeculizumabhemolytic uremic syndromethrombotic microangiopathythrombotic thrombocytopenic purpuraMore Related Videos
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
1.1K
05:30Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
Published on: November 8, 2024
830
Related Concept Videos
01:30Venous Thrombosis I: Introduction
189
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
189
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
01:29Venous Thrombosis III: Interprofessional Care
209
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
209
01:07Teratogenicity
3.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
01:24Disorders of Hemostasis
1.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.8K
01:30Venous Thrombosis IV: Nursing Management
148
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
148